Phase I/IIa PET imaging study with 89zirconium labeled anti-PSMA minibody for urological malignancies

Overview of attention for article published in Annals of Nuclear Medicine, November 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 39 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 23 publications that cite this research output.

23

The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.

Commercialization potential of PET (polyethylene terephthalate) recycled nanomaterials: A review on validation parameters

Article in Chemosphere (February 2024)

From Bench to Bedside: Patient-Oriented Radiopharmaceutical Development in Nuclear Medicine Based on the Example of [89Zr]Zr-PSMA-DFO

Article in Molecules (December 2023)

Zirconium immune-complexes for PET molecular imaging: Current status and prospects

Article in Coordination Chemistry Reviews (March 2023)